The "fat jab," also known as Saxenda or liraglutide, is an injectable weight-loss drug that has been approved for use on the NHS in the UK for individuals struggling with obesity. It is intended for use in conjunction with a reduced-calorie diet and increased physical activity. The medication helps control appetite, leading to weight loss. It is typically prescribed to those with a BMI over 30 or individuals with weight-related health problems.

A non-surgical sleeve refers to procedures that mimic the effects of sleeve gastrectomy but without surgery. One such method is the Endoscopic Sleeve Gastroplasty (ESG), which reduces stomach size using sutures inserted through an endoscope. This approach is less invasive, has a faster recovery time, and is typically used for patients who do not qualify for surgical interventions.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

Always consume lean protein first, non-starchy vegetables second, and high-fiber carbs or a healthy fat source last. Try to consume at least 64 ounces of hydrating fluids. Avoid added-sugar drinks, carbonation, and excessive caffeine. Consume alcohol in moderation. The altered bowel motility and absorption as a result of weight-loss surgery also can result in more or smellier gas. Noise associated with gas can be from the abdomen (bowel sounds) or with the passage of gas through the anus (or an ostomy). In... +More